Gene · 129607
CMPK2: cytidine/uridine monophosphate kinase 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CMPK2: cytidine/uridine monophosphate kinase 2. Genes, record 129607. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/129607
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q5EBM0 | UMP-CMP kinase 2, mitochondrial | 449 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents11
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 42759 | Q5EBM0 | Espacenet |
| US 11617761 B2 | 2023-04-04 | 1 | Q5EBM0 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 21675 | Q5EBM0 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 124646 | Q5EBM0 | Espacenet |
| US 10869880 B2 | 2020-12-22 | 1 | Q5EBM0 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 223194 | Q5EBM0 | Espacenet |
| JP 2017121241 A | 2017-07-13 | 223194 | Q5EBM0 | Espacenet |
| JP 2015516143 A | 2015-06-08 | 223194 | Q5EBM0 | Espacenet |
| EP 2052088 A2 | 2009-04-29 | 7584 | Q5EBM0 | Espacenet |
| JP 2006516089 A | 2006-06-22 | 4141 | Q5EBM0 | Espacenet |
1 to 10 of 11
See all 11 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,236
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CMPK2 papers | Newest fiscal year |
|---|---|---|---|
| T32CA154274 | Training Grant in Cancer Biology | 8 | 2025 |
| P30CA014195 | Cancer Center Support Grant (CCSG) | 5 | 2025 |
| P20GM103436 | IDeA Networks of Biomedical Research Excellence in Kentucky | 3 | 2025 |
| P30AI094189 | The Johns Hopkins Center for AIDS Research (JHU CFAR) | 3 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 3 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 3 | 2025 |
| P30CA134274 | UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANT | 3 | 2025 |
| P30DK050306 | Center for Molecular Studies in Digestive and Liver Diseases | 3 | 2025 |
| R01NS076511 | Lipid Imaging in Traumatic Brain Injury by High Resolution GCIB-secondary Ion Mass Spectrometry | 3 | 2025 |
1 to 10 of 1,236Source NIH's project files
See all 1,236 nih grantsPapers1,751
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nucleotide metabolic reprogramming: a "double-edged sword" in obesity-related inflammation-from metabolic adaptation to pathological imbalance. | J Physiol Biochem | 2026 | 42799975 | PubTator, text mining | PubMed |
| Interferome profiling in the blood links IFNα5-Mucin-1 axis to HIV-1 pathogenesis. | J Virol | 2026 | 42788733 | PubTator, text mining | PubMed |
| Recent insights on cell-type-specific lactylation driving neuropathic pain chronification. | Neurochem Int | 2026 | 42648441 | PubTator, text mining | PubMed |
| CCL20 Released by Drug-Tolerant Persisters Impairs Immunotherapy in EGFR-Mutant Lung Adenocarcinoma. | MedComm (2020) | 2026 | 42549034 | PubTator, text mining | PubMed |
| RSAD2/VIPERIN and CMPK2 coordinate an immunometabolic response to Epstein-Barr Virus. | PLoS Pathog | 2026 | 42546073 | PubTator, text mining | PubMed |
| Reconfiguration of the Microtubule Network and Dynamics in Hypoxic Cancer Cells. | Chem Biomed Imaging | 2026 | 42529405 | PubTator, text mining | PubMed |
| Functional and transcriptome analyses identify CMPK2 as a potential antiviral factor against NNV in Siniperca chuatsi. | Dev Comp Immunol | 2026 | 42468658 | PubTator, text mining | PubMed |
| Letter to editor: Mitochondrial DNA release contributes to neuropathic pain via a cGAS-STING-IRF3 CMPK2-associated immunometabolic feedback mechanism. | J Transl Med | 2026 | 42458472 | PubTator, text mining | PubMed |
| Identification of key metabolic enzymes involved in the activation of obeldesivir and remdesivir to the active triphosphate metabolite. | Antimicrob Agents Chemother | 2026 | 42363837 | PubTator, text mining | PubMed |
| Integrated Downstream Analysis and Epidemiological Modelling of Hantavirus Infection: From Host Transcriptomics to Transmission Dynamics. | Pathogens | 2026 | 42347213 | PubTator, text mining | PubMed |
1 to 10 of 1,751
See all 1,751 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/129607
GET https://conductscience.org/api/genes/v1/129607/patents